This comprehensive review delves into the forefront of biosensor technologies and their critical roles in disease biomarker detection and therapeutic drug monitoring. It provides an in-depth analysis of various biosensor types and applications, including enzymatic sensors, immunosensors, and DNA sensors, elucidating their mechanisms and specific healthcare applications. The review highlights recent innovations such as integrating nanotechnology, developing wearable devices, and trends in miniaturisation, showcasing their transformative potential in healthcare. In addition, it addresses significant sensitivity, specificity, reproducibility, and data security challenges, proposing strategic solutions to overcome these obstacles. It is envisaged that it will inform strategic decision-making, drive technological innovation, and enhance global healthcare outcomes by synthesising multidisciplinary insights.

A new fluorescence chemosensor based on ( Z )-2-(1-(3-oxo-3 H -benzo[ f ]chromen-2-yl)ethylidene)hydrazine-1-carbothioamide (CEHC) has been developed for the determination of the fluorescence probe of Fe( iii ) in drinking water.

A highly sensitive, selective and rapid method for the determination of cobalt based on the rapid reaction of cobalt(II) with 5-(2-benzothiazolylazo)-8-hydroxyquinolene BTAHQ and the solid phase extraction of the Co(II)-BTAHQ complex with C18 membrane disks were developed. In the presence of pH = 6.4 buffer solution and cetylpyridenium chloride (CPC) medium, BTAHQ reacts with cobalt to form a deep violet complex with a molar ratio of 1:1 (cobalt to BTAHQ). This complex was enriched by the solid phase extraction with C18 membrane disks. An enrichment factor of 100 was obtained by elution of the complex from the disks with a minimal amount of isopentyl alcohol. In isopentyl alcohol medium, the molar absorptivity of the complex is 2.42 × 10⁵ L mol⁻¹ cm⁻¹ at 658 nm. Beer’s law is obeyed in the range of 0.01–0.38 μg mL⁻¹ in the measured solution. The relative standard deviation for 11 replicate samples of 0.20 μg mL⁻¹ level is 1.37%. The detection and quantification limits reach 3.1 and 9.7 ng mL⁻¹ in the original samples. This method was applied for the determination of cobalt in biological, water, soil and pharmaceutical preparation samples with good results.

A novel sensitive, selective, and reversible cobalt(II) ion optical sensor was prepared by the incorporation of 5-[o-carboxyphenylazo]2,4-dihydroxybenzoic acid [CPDB] and sodium tetraphenylborate (NaTPB) in a plasticized polyvinyl chloride (PVC) membrane containing dioctyl adipate (DOA) as a plasticizer. The influence of several parameters such as pH, base matrix, solvent mediator and reagent concentration was optimized. A comparison of the obtained results with those of previously reported sensors revealed that the proposed method, in addition to being fast and simple, provided a good linear range (0.05–45.20 μM) and low detection limit (0.015 μM). Low detection and quantification limits and excellent selectivity in the presence of interfering ions such as Fe³⁺, Cu²⁺, Ni²⁺, Ag⁺, Au³⁺, Cr³⁺, Cd²⁺, Zn²⁺, Hg²⁺, and SO₄ ²⁻ make it feasible to monitor Co²⁺ ion content accurately and repeatedly in environmental samples with complicated matrices. The optode was regenerated successfully using 0.3 M nitric acid (HNO₃) solution while its response was reversible with a relative standard deviation (RSD) lower than 1.9% for seven replicate determinations of 20 μM Co²⁺ in various membranes. The optode was stable and was stored for at least 15 days without observing any change in its sensitivity.